background preloader

Pharmaceuticals Market Research Reports

Facebook Twitter

MarketsAndMarkets presents here the Top Market Research Reports on Pharmaceuticals Industry.
The global pharmaceuticals market is experiencing constant growth due to the worldwide increase in life expectancy, as well as the increasing incidence of chronic and infectious diseases.

The steadily increasing demand for innovative drugs has thus triggered a significant rise in R&D investments in the pharmaceuticals industry. Active Pharmaceutical Ingredient (API) Market (2011-2016): Trends, Competitive Landscape and Global Forecasts, Market Research Report: MarketsandMarkets. Anesthesia Drugs Market 2011-2015, U.S. Ketamine Market Research Report :MarketsandMarkets. The U.S. general anesthesia drugs market is poised to reach USD 2.0 Billion by 2020 from USD 1.6 Billion in 2015, at a CAGR of 3.8% from 2015 to 2020.

Anesthesia Drugs Market 2011-2015, U.S. Ketamine Market Research Report :MarketsandMarkets

In-Vitro Diagnostics (IVD) Market: Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture – Global Trends & Forecasts to 2016, Market Research Report :MarketsandMarkets. Factors such as the continuous technological advancements in the field of diagnostics and an increase in healthcare awareness have made In Vitro Diagnostic testing an indispensable tool in current medical practices.

In-Vitro Diagnostics (IVD) Market: Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture – Global Trends & Forecasts to 2016, Market Research Report :MarketsandMarkets

Biosimulation Market & Insilico Technology Research Report - Forecasts 2012-17. The biosimulation market is expected to reach USD 2,107.99 Million by 2020 from USD 1,034.93 Million in 2015, at a CAGR of 15.29%.

Biosimulation Market & Insilico Technology Research Report - Forecasts 2012-17

Biosimulation refers to the modeling and simulation of complex biological processes and systems to understand their functions and physiologies at the molecular level. Autologous Stem Cell Market & Non-stem Cell Therapy Market - Forecasts 2012-17. This research report titled “Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017)” provides details about various autologous cell based treatments and their application areas.

Autologous Stem Cell Market & Non-stem Cell Therapy Market - Forecasts 2012-17

Every health regulatory bodies will be expecting companies and universities to develop therapy treatments, which are Safer, Affordable, Robust, Rapid, Easy to use, Effective and Deliverable to the end user. Autologous stem cell transplantation for particular application areas is safe experiencing robust growth and has minimal steps of procedure to follow and is rapid in deriving the results. The sources for autologous stem cell therapy are Mesenchymal stem cells, Hematopoietic stem cells, Chondrocytes and so on. Currently, the cost of the treatments is not affordable however, by the intrusion of government bodies, this mode of treatment will certainly experience an immense market growth.

Smart Pill Technology Market, Digital Pills, Capsule Endoscopy Market Size, Forecasts 2012-17. The global smart pills market is segmented on the basis of applications and regions.

Smart Pill Technology Market, Digital Pills, Capsule Endoscopy Market Size, Forecasts 2012-17

Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Report - Forecasts 2012-17. The research analysis titled “Isothermal Nucleic Acid (Gene) Amplification Technologies (INAAT)” discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale.

Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Report - Forecasts 2012-17

The World Health Organization (WHO) proposes that, an ideal diagnostic test (DNA test kits, RNA test kit etc) that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end-user (ASSURED). Nucleic acid diagnostics targeting pathogen markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of affordability, rapidity, and being equipment free.

In brief, this research report provides: It is worthy to mention that INAAT existed in parallel with PCR and yet its market potential was never exploited to the extent of PCR. Advanced Wound Care Market Research Report, Global Forecasts to 2016 :MarketsandMarkets. The global wound care market is expected to reach $18.3 billion by 2019 from $15.6 billion in 2014, growing at a CAGR of 3.2% from 2014 to 2019.

Advanced Wound Care Market Research Report, Global Forecasts to 2016 :MarketsandMarkets

The factors driving the market growth include government support in the form of funding for development of wound care products, increasing diabetic and obese population, and rising aging population are providing required impetus for growth of the market. However, factors such as high costs of advanced wound care products may restrain the market growth. North America dominates the wound care market with the U.S. accounting for the major market share.

Asia is poised to grow at the highest CAGR during the forecast period, owing to the increasing awareness for wound healing products, rising aging population, rising diabetic wounds due to changing lifestyle factors, and growing population with pressure ulcers. Furthermore, many giant players are focusing on the market in Asia. Scope of the Report. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications) (2012 - 2017) The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64%.

Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications) (2012 - 2017)

Epigenetics is defined as the study of the heritable changes in gene expression, without any changes to the main DNA sequence. In other words, epigenetics refers to covalent modification of DNA, RNA, or protein. High prevalence of cancer; increasing R & D funding; increasing intensity of research activities; increasing application for non-oncology diseases; and growing partnership between academic, biotechnology and pharmaceutical companies are driving factors of the epigenetics market.